The low-LET radiation contribution to the tumor dose in diffusing alpha-emitters radiation therapy

TL;DR

This study evaluates the low-LET radiation contribution from diffusing atoms in Alpha DaRT, showing that electron and photon emissions significantly enhance tumor dose while sparing healthy tissue, using Monte Carlo simulations.

Contribution

It introduces a comprehensive method to quantify low-LET dose contributions in Alpha DaRT, including electron and photon emissions, and compares simple and realistic source models.

Findings

Low-LET dose can reach 18-30 Gy between sources.

Low-LET dose drops below 5 Gy at 3 mm distance.

Increasing source activity enhances therapeutic dose levels.

Abstract

Diffusing alpha-emitters Radiation Therapy (Alpha DaRT) enables the use of alpha particles for the treatment of solid tumors. It employs interstitial sources carrying a few uCi of Ra-224, designed to release its short-lived progeny, which emit alpha particles, beta, Auger, and conversion electrons, x- and gamma rays. These atoms diffuse around the source and create a lethal high-dose region, measuring a few mm in diameter. Previous studies focused on the alpha dose alone. This work addresses the electron and photon contributed by the diffusing atoms and by the atoms on the source surface, for both a single source and multi-source lattices. This allows to evaluate the low-LET contribution to the dose and demonstrate the sparing of surrounding healthy tissue. The dose is calculated using Monte Carlo codes. We compare the results of a simple line-source to those of a full simulation, which implements a realistic source geometry and the spread of the diffusing atoms. We consider two extreme scenarios: low diffusion and high Pb-212 leakage, and high diffusion and low leakage. The low-LET dose in source lattices is calculated by superposition of single-source contributions. We found that for sources carrying 3 uCi/cm Ra-224 arranged in a hexagonal lattice with 4 mm spacing, the minimal low-LET dose between sources is 18-30 Gy for the two scenarios and is dominated by the beta contribution. The low-LET dose drops below 5 Gy 3 mm away from the lattice. The accuracy of the line-source approximation is 15% for the total low-LET dose over clinically relevant distances (2-4 mm). For 3 uCi/cm Ra-224 sources, the contribution of the low-LET dose can reduce cell survival by up to 2-3 orders of magnitude. Increasing source activities by a factor of 5 can bring the low-LET dose to therapeutic levels leading to a self-boosted configuration, and potentially allowing to increase the lattice spacing.